12348 1 ap (Proteintech)
Structured Review
12348 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/12348 1 ap/product/Proteintech
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
fabp5 rabbit polyclonal antibody (Proteintech)
Structured Review
Fabp5 Rabbit Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fabp5 rabbit polyclonal antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Adenosine-rich extract of Ganoderma lucidum: A safe and effective lipid-lowering substance"
Article Title: Adenosine-rich extract of Ganoderma lucidum: A safe and effective lipid-lowering substance
Journal: iScience
doi: 10.1016/j.isci.2022.105214
Figure Legend Snippet: The levels of proteins and PTMs in the PPAR signaling pathway
Techniques Used: Expressing, Significance Assay, Modification
Figure Legend Snippet:
Techniques Used: Software
goat anti rabbit secondary antibody (Proteintech)
Structured Review
Goat Anti Rabbit Secondary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti rabbit secondary antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
rabbit anti human fabp5 primary antibody (Proteintech)
Structured Review
Rabbit Anti Human Fabp5 Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti human fabp5 primary antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Fatty acid binding protein 5 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by degradation of Krüppel-like factor 9 mediated by miR-889-5p via cAMP-response element binding protein"
Article Title: Fatty acid binding protein 5 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by degradation of Krüppel-like factor 9 mediated by miR-889-5p via cAMP-response element binding protein
Journal: Cancer Biology & Therapy
doi: 10.1080/15384047.2022.2094670
Figure Legend Snippet: FABP5 expression was upregulated in HCC. a, expression of FABP5 in HCC samples (N = 369) and normal samples (N = 160) from the TCGA data set. b, relative expression of FABP5 mRNA in HCC tissues compared with adjacent normal tissues were detected by RT-qPCR. c, relative expression of FABP5 protein in HCC tissues and adjacent normal tissues were detected by western blotting. Representative images of FABP5 expression in 48 paired HCC tissues(t) and adjacent normal tissues (n). d, the expression of FABP5 was negatively correlated with overall survival time in HCC patients from the TCGA data set. * P < .05 and *** P < .001 as compared with the vehicle control.
Techniques Used: Expressing, Quantitative RT-PCR, Western Blot
Figure Legend Snippet: Correlation between FABP5 expression and clinicopathological characteristics
Techniques Used: Expressing
Figure Legend Snippet: FABP5 knockdown inhibited cell growth, migration and invasion in HCC cells. a, the mRNA and protein expression levels of FABP5 were analyzed in FABP5-knockdown HepG2 and SK-Hep-1 cells by RT-qPCR and western blotting. b, the growth curve of HCC cells was determined by CCK-8 assay. c, PI fluorescence pattern was applied for cell-cycle distribution in HCC cells transfected with shFABP5 or shNC. d, HCC cells transfected with shFABP5 or shNC were stained with Annexin-V FITC and PI to be measured apoptosis. Apoptotic cells are presented in the right-lower (Q3, early apoptosis) and right-upper (Q2, late apoptosis) quadrants of the plots. e, transwell assay revealed the migration abilities of HCC cells transfected with shFABP5 or shNC. f, transwell assay revealed the invasive abilities of HCC cells transfected with shFABP5 or shNC. Results are presented as mean ± S.E.M. (N = 3). Results were averaged from three independent experiments and presented as percentage of control levels. * p < .05, ** p < .01 and *** p < .001 as compared with the vehicle control. FITC, fluorescein isothiocyanate; PI, propidium iodide.
Techniques Used: Migration, Expressing, Quantitative RT-PCR, Western Blot, CCK-8 Assay, Fluorescence, Transfection, Staining, Transwell Assay
Figure Legend Snippet: Decreased expression of FABP5 inhibited the growth of HCC cells in vivo. a, HepG2 cells and HepG2 cells stably transfected with shFABP5 RNA or shNC were implanted into nude mice by subcutaneous injection. Tumor volume was measured each 7 days by a calliper until the end of the experiment. The tumor growth curve was drawn. b, the mice and the tumors of different groups on the 28th day after injection. c, the weight of each xenograft tumor was measured at the end of the experiment. d, the differences in FABP5 mRNA levels between the shFABP5 group and the control groups were detected by RT-qPCR. e, the protein levels of FABP5 in the shFABP5 group and the control groups were measured by western blotting. f, the tumors were analyzed by immunohistochemical staining with anti-FABP5. Original magnification: 400 × . *** p < .001 as compared with the vehicle control.
Techniques Used: Expressing, In Vivo, Stable Transfection, Transfection, Injection, Quantitative RT-PCR, Western Blot, Immunohistochemical staining, Staining
Figure Legend Snippet: The expression of KLF9 was negatively correlated with FABP5. a, gene microarray analysis were applied to examine the differential expression genes in SK-Hep-1 cells before and after FABP5 knockdown (FC > |2|; P < .01). b, gene ontology (GO) enrichment analysis of differential expression genes in accordance with the biological processes, cellular component, and molecular function. c, KLF9 mRNA expression in HepG2 and SK-Hep-1 cells with FABP5 knockdown determined by RT-qPCR. d, the KLF9 expression in HCC tissue and adjacent tissues were detected by RT-qPCR. e, relative expression of KLF9 protein in HCC tissues and adjacent normal tissues were detected by Western blotting. Representative images of KLF9 expression in 48 paired HCC tissues (t) and adjacent normal tissues (n). e, the expression of KLF9 was positively correlated with overall survival time in HCC patients from the TCGA data set. F, A negative correlation was found between the protein expression level of FABP5 and KLF9 in HCC samples. *p < .05, **p < .01, and ***p < .001 as compared with the vehicle control.
Techniques Used: Expressing, Microarray, Quantitative RT-PCR, Western Blot
Figure Legend Snippet: KLF9 knockdown reversed the phenotypes caused by FABP5 knockdown in HCC cells. a-b, HepG2 and SK-Hep-1 cells upon co-transfection of shFABP5 with shKLF9 showed significantly reduced KLF9 expression at the mRNA and protein levels. c, CCK-8 assay showed that shKLF9 significantly reversed the inhibition of proliferation induced by FABP5 knockdown in HCC cells. d, transwell migration assay revealed that shKLF9 significantly rescued the migratory inhibition induced FABP5 knockdown in HCC cells. e, transwell invasion assay revealed that shKLF9 significantly rescued the inhibition of invasion induced by FABP5 knockdown in HCC cells. F, KLF9 knockdown reversed the cell cycle arrest caused by FABP5 knockdown in HCC cells. PI fluorescence pattern was applied for cell-cycle distribution. G, KLF9 knockdown reversed the apoptosis caused by FABP5 knockdown in HCC cells. HepG2 and SK-Hep-1 cells were stained with Annexin-V FITC and PI to be measured apoptosis. Apoptotic cells are presented in the right-lower (Q3, early apoptosis) and right-upper (Q2, late apoptosis) quadrants of the plots. Results are presented as mean ± S.E.M. (N = 3). * p < .05, ** p < .01, and ***p < .001 as compared with the vehicle control. Results were averaged from three independent experiments and presented as percentage of control levels. FITC, fluorescein isothiocyanate; PI, propidium iodide.
Techniques Used: Cotransfection, Expressing, CCK-8 Assay, Inhibition, Transwell Migration Assay, Transwell Invasion Assay, Fluorescence, Staining
Figure Legend Snippet: PI3K/AKT signaling pathway was involved in FABP5-induced KLF9 downregulation. a, KEGG pathway enrichment analysis of top 20 differentially expressed signaling pathways in FABP5 knockdown group compared with control group in SK-Hep-1 cells. b, PI3K/AKT signaling pathway was analyzed by western blotting in the indicated groups.
Techniques Used: Western Blot
Figure Legend Snippet: miR-889-5p suppressed KLF9 expression by directly targeted KLF9. a, the expression of miR-889-5p was significantly decreased by FABP5 knockdown in HCC cells. b, bioinformatics analysis predicted that the 3ʹUTR sequence of KLF9 is complementary to the seed sequence of miR-889-5p.The core binding sequences of KLF9 were mutated (in red text). c, dual-luciferase reporter assay was performed to verify that miR-889-5p directly bound to the 3’-UTR sequences of KLF9 in the cells co-transfected with miR-889 mimics or NC with pGL3-KLF9-WT or pGL3-KLF9-Mut. d, relative expression of miR-889-5p in 48 HCC tissues compared with adjacent normal tissues was detected by RT-qPCR. E, miR-889-5p expression was negatively correlated with KLF9 expression and positively correlated with FABP5 expression in HCC tissues. f-g, increased expression of miR-889-5p attenuated KLF9 mRNA and protein expression of in HCC cells with shFABP5 treatment. *p < .05, **p < .01, and ***p < .001 as compared with the vehicle control.
Techniques Used: Expressing, Sequencing, Binding Assay, Luciferase, Reporter Assay, Transfection, Quantitative RT-PCR
Figure Legend Snippet: FABP5 inhibits the expression of miR-889-5p by regulating CREB protein phosphorylation. a, the siRNA of NF-κB, c-Myc and CREB were transiently transferred into HepG2 and SK-Hep-1 cells. The expression of miR-889-5p was detected by RT-qPCR. b, the designed mutative model of miR-889-5p promoter. c, a luciferase reporter promoter system was employed to confirm CREB bind to miR-889-5p promoter. d, the expression of total and phosphorylated CREB protein were detected by western blotting in the indicated groups. e, CREB inhibitor KG-501 reverse the effect of FABP5 overexpression on miR-889-5p expression in HCC cells. **p < .01 and ***p < .001 as compared with the vehicle control. e, the scheme of the mechanism by which FABP5 affects HCC tumorigenesis. FABP5 improves CREB protein phosphorylation to upregulate the miR-889-5p expression by CREB binding to the miR-889-5p promoter region, whereby leading to downregulation of KLF9 by miR-889-5p binding to the 3ʹ-UTR of the KLF9 mRNA, potentiating the PI3K/AKT signaling pathway and promoting the proliferation, migration, and invasion of HCC cells.
Techniques Used: Expressing, Quantitative RT-PCR, Luciferase, Western Blot, Over Expression, Binding Assay, Migration
anti fabp5 antibody (Proteintech)
Structured Review
Anti Fabp5 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti fabp5 antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages"
Article Title: Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages
Journal: Nature Communications
doi: 10.1038/s41467-021-27428-9
Figure Legend Snippet: a Schematic of the enrichment and quantitative analysis for SSG-modified Cys-peptides. b Enrichment of protein SSG and LC–MS/MS in BMDMs exposed to H 2 O 2 (200 μM) for 0, 15 min. Gene ontology annotations for biological process of proteins with significant S-glutathionylation alterations found to be increased or decreased in any stage by >1.2-fold compared to control. The slice for metabolic process is slightly displaced from the rest of the pie chart. c Alterations in S-glutathionylation sites under exposure to H 2 O 2 [shown as fold changes of protein S-glutathionylation (H 2 O 2 treated/control). Gray, identified protein sites; blue, metabolism-related differential proteins; orange, FABP5]. d mRNA levels of Ptbp1 , Otub1 , Ctsz , Gapdh , and Fabp5 in BMDMs as evaluated by qPCR, n = 3 biologically independent samples over 3 independent experiments, data are shown as mean ± SEM and analyzed with a 95% confidence interval, P < 0.0001, one-way ANOVA is followed by Tukey’s post-hoc test. Source data are provided as a Source Data file.
Techniques Used: Modification, Liquid Chromatography with Mass Spectroscopy
Figure Legend Snippet: a mRNA levels of FABP family members in RAW264.7 cells as determined by qPCR, n = 3 biologically independent samples over three independent experiments, data are presented as mean ± SEM and analyzed with a 95% confidence interval, P <0.0001, N.D, not detected, one-way ANOVA is followed by Tukey’s post-hoc test. b Protein levels of FABP5 in macrophages (MH-S), lung cancer cells (A549), epithelial cells (MLE-12), endothelial cells (HUVEC), fibroblasts (HFL1), and neutrophils (primary neutrophils) as evaluated by immunoblot. c Levels of FABP5 evaluated by immunoblot in RAW264.7 cells exposed to H 2 O 2 (200 μM) for indicated time (β-actin, loading control). d mRNA levels of Fabp5 in RAW264.7 cells after exposure to H 2 O 2 (200 μM) for indicated time as determined by qPCR, n = 3 biologically independent samples over three independent experiments, data are shown as mean ± SEM and analyzed with a 95% confidence interval, one-way ANOVA is followed by Tukey’s post-hoc test. e Co-IP of S-glutathionylation of FABP5 in COS-7 cells co-transfected with pXJ40-3xFlag-FABP5 and pcDNA3.1-3xFlag-Grx1 (or vector) and exposed for 15 min to H 2 O 2 (200 μM) at 24 h post-transfection (IP, GSH; IB, FABP5). Whole cell lysates confirm the expression of FABP5, Grx1, and β-actin (DTT, negative control). f Co-IP showing S-glutathionylation of FABP5 in BMDMs (from control or Grx1 KO mice) after exposure to H 2 O 2 (200 μM) for 15 min (IP, GSH; IB, FABP5). Whole cell lysates confirm the expression of FABP5, Grx1, and β-actin (DTT, negative control). g Immunoblotting analysis of reducing or non-reducing SDS–PAGE of RAW264.7 cells after exposure to H 2 O 2 (at the indicated concentration) for 15 min. h COS-7 cell lysates subjected to SDS-PAGE under reducing or non-reducing conditions after transfection of pXJ40-3xFlag vector or pXJ40-3xFlag-FABP5 and exposure to H 2 O 2 (200 μM) for 15 min. i Co-IP for S-glutathionylation of FABP5 in WT BMDMs after treatment with LPS (100 ng/mL) for 15 min (IP, GSH; IB, FABP5). Whole cell lysates confirm the expression of FABP5 and β-actin. j S-glutathionylation of FABP5 in lung tissues from Grx1 fl/fl and Grx1 fl/fl LysM cre mouse 24 h following intratracheal administration of PBS or LPS. Source data are provided as a Source Data file.
Techniques Used: Western Blot, Co-Immunoprecipitation Assay, Transfection, Plasmid Preparation, Expressing, Negative Control, SDS Page, Concentration Assay
Figure Legend Snippet: a – c Immunoblot analysis of FABP5 binding to ULCFA ( a ), SLCFA ( b ) or ULCFA with Grx1 treatment ( c ). Purified recombinant FABP5 protein was incubated with GSH plus H 2 O 2 or GSSG for 15 min, then mixed with Biotin-ULCFA or Biotin-SLCFA in the absence or presence of BMS309403 or linoleic acid or Grx1. FABP5 interacted with the Biotin-ULCFA or Biotin-SLCFA was captured using streptavidin magnetic beads. d Immunofluorescence staining of BMDMs after exposure to H 2 O 2 (200 μM) for 30 min (green, FABP5; blue, DAPI; scale bars, 10 μm). e Quantitative analysis of the ratio of nuclear/cytoplasmic fluorescence intensity in BMDMs as in ( d ), n = 10 in each group, P (ctr vs. ctr H2O2) = 0.0172, P (ctr H2O2 vs. Grx1 KO H2O2) <0.0001. f Immunoblot analysis of cytoplasmic and nuclear FABP5 in COS-7 cells. COS-7 cells were transfected with pXJ40-3xFlag vector or pXJ40-3xFlag-FABP5 followed by exposure to H 2 O 2 (200 μM) for 1 h. Lamin B1 (nuclear fraction) and GAPDH (cytoplasmic fraction) are loading controls. g Immunoblots with antibodies against the indicated proteins in nuclear and cytoplasmic fractions from COS-7 cells co-transfected with pXJ40-3xFlag-FABP5 (or vector) and pcDNA3.1-3xFlag-Grx1 (or vector) for 24 h, then exposed to H 2 O 2 (200 μM) for 1 h. h Immunoblots against the indicated proteins of cytoplasmic and nuclear extracts from BMDMs exposed to H 2 O 2 (200 μM) for 1 h. i mRNA expression of Il1b , Il6 , and Tnfα in BMDMs from mice stimulated with LPS (100 ng/mL) for 4 h, as evaluated by qPCR, n = 3 in each group, P ( Il1b , Ctr vs. Ctr+LPS) = 0.0013, P ( Il1b , Ctr+LPS vs. Grx1 KO+LPS) = 0.0091, *** P < 0.0001. j mRNA levels of Il1b , Il6 , and Tnfα in BMDMs pre-treated with an FABP5 inhibitor (SBFI26, 100 μM) for 2 h and stimulated with LPS (100 ng/mL) for 4 h, as determined by qPCR, n = 3 in each group, *** P < 0.0001. k mRNA levels of Il1b , Il6 , and Tnfα in BMDMs after treated with SBFI26 (100 μM) for 2 h and stimulation with LPS (100 ng/mL) for 4 h, as evaluated by qPCR, n = 3 in each group, P ( Il1b , Ctr+LPS vs. Ctr+LPS+inhibitor) < 0.0001, P ( Il16 , Ctr+LPS vs. Ctr+LPS+inhibitor) < 0.0001, P ( Tnfα , Ctr+LPS vs. Ctr+LPS+inhibitor) = 0.0046. All samples were biologically independent and three or more independent experiments were performed. All quantitative data are shown as mean ± SEM and analyzed with a 95% confidence interval. One-way ANOVA followed by Tukey’s post-hoc test for (e, i-k). * P < 0.05, ** P < 0.01, *** P < 0.001, ns = no significance. Source data are provided as a Source Data file.
Techniques Used: Western Blot, Binding Assay, Purification, Recombinant, Incubation, Magnetic Beads, Immunofluorescence, Staining, Fluorescence, Transfection, Plasmid Preparation, Expressing
Figure Legend Snippet: a Model structure of FABP5 and its 6 cysteines, generated by Pymol and based on the crystal structure of Homo sapiens FABP5 (PDB ID,4LKT). b Mass spectra of a peptide from FABP5 including glutathionylated cysteine 120 and cysteine127. c Immunofluorescence staining (with FABP5) and confocal microscopy imaging of COS-7 cells with overexpression of FABP5 WT, C67S, C87S, C120S, and C127S after exposure to H 2 O 2 (200 μM) for 1 h (green, FABP5; blue, DAPI; scale bars, 10 μm). d Immunoblot analysis of cytoplasmic and nuclear FABP5 in COS-7 cells transfected with FABP5 WT or C127S after exposure to H 2 O 2 (200 μM) for 1 h. Lamin B1 (nuclear fraction) and GAPDH (cytoplasmic fraction) are loading controls. e Model structure of FABP5 interaction with an FA (Fatty Acid, Linoleic Acid), generated by Pymol and based on the crystal structure of FABP5 (PDB ID, 4LKT). f Docking structure of FABP5 in complex with S-glutathionylated Cys127 interacting with an FA (Fatty Acid, Linoleic Acid). g Docking structure of dimer FABP5 (PDB ID, 4AZM, Homo sapiens ) in complex with reduced glutathione (GSH) on Cys127. h Co-IP for S-glutathionylation of FABP5 in COS-7 cells overexpressing pXJ40-3xFlag-FABP5 WT or C127S and exposed to H 2 O 2 (200 μM) for 15 min (IP, GSH; IB, FABP5). Whole-cell lysates confirm the expression of FABP5 and β-actin (DTT, negative control). i Immunoblot analysis of FABP5 fatty acid binding. Purified recombinant FABP5 WT or C127S protein (1 μg) was incubated with GSSG (1 mM) for 15 min, then mixed with Biotin-linoleic acid in the absence or presence of BMS309403 (5 mM) for 30 min. FABP5 that associated with the Biotin-linoleic acid was captured using streptavidin magnetic beads. Source data are provided as a Source Data file.
Techniques Used: Generated, Immunofluorescence, Staining, Confocal Microscopy, Imaging, Over Expression, Western Blot, Transfection, Co-Immunoprecipitation Assay, Expressing, Negative Control, Binding Assay, Purification, Recombinant, Incubation, Magnetic Beads
Figure Legend Snippet: a Volcano plot of RNA-seq transcriptome data displaying the pattern of gene expression values for FABP5 KO BMDMs with overexpression of FABP5 C127S relative to FABP5 WT after exposure to LPS (500 ng/mL) for 24 h [red and blue dots, significantly up-and down-regulated genes ( P < 0.01, |log 2 FC|>1); black dashed lines, boundary for identification of up- or down-regulated genes]. b Heatmap of regulation of the inflammatory response and cytokine transcript production in LPS-stimulated (24 h) BMDMs nucleofected with either pXJ40-3xFlag-FABP5 WT or C127S. Data shown are relative to the calculated Z scores across the samples. Red, relatively high levels of expression; blue, relatively low levels of expression. Each column represents one individual (for a total of 3 per group) and each row represents the expression of a single gene. c Diagram of GO analysis classifying DEGs into biological process groups using Panther ( http://www.pantherdb.org ). Some GO categories with FDR <0.05 are included. GO, gene ontology; DEGs, differentially-expressed genes. d mRNA expression of Il1b , Il6 , and Tnfα in FABP5 KO BMDMs after nucleofection with pXJ40-3xFlag-FABP5 WT or C127S and stimulation with LPS (1 μg/mL) for 24 h, as identified by qPCR, n = 3 in each group, P ( Il6 , FABP5 WT+LPS vs. FABP5 C127S+LPS) = 0.0045, *** P < 0.0001. e mRNA expression of Il1b , Il6 , and Tnfα in Grx1 KO BMDMs after nucleofection of pXJ40-3xFlag-FABP5 WT or C127S and treatment with LPS (500 ng/mL) for 24 h, as determined by qPCR, n = 3 in each group, P ( Il6 , Ctr+FABP5 C127S vs. Grx1 KO+FABP5 C127S) = 0.0004, P ( TNFα , Ctr+FABP5 WT vs. Grx1 KO+FABP5 WT) = 0.0123, *** P < 0.0001(except group Il6 , Ctr+FABP5 C127S vs. Grx1 KO+FABP5 C127S). f H&E staining showing lung histopathological changes in FABP5 fl/fl and FABP5 fl/fl LysM cre mice 24 h after intratracheal administration of PBS or LPS (5 mg/kg). Scale bars, 50 μm. g Total numbers of leukocytes in BALF from FABP5 fl/fl and FABP5 fl/fl LysM cre mice 24 h after intratracheal administration of PBS or LPS (5 mg/kg), n = 4, 4, 9, 8, respectively, *** P < 0.0001. All samples were biologically independent and three or more independent experiments were performed. All quantitative data are shown as mean ± SEM and analyzed with a 95% confidence interval. One-way ANOVA followed by Tukey’s post-hoc test for ( d – e , g ). * P < 0.05, ** P < 0.01, *** P < 0.001. Source data are provided as a Source Data file.
Techniques Used: RNA Sequencing Assay, Expressing, Over Expression, Staining
Figure Legend Snippet: a In vitro pull-down assays. The mouse recombinant FABP5 (WT or C127S) protein with 3xFlag tag purified from E. coli treated with GSSG (1 mM) for 15 min was incubated with COS-7 lysates and precipitated with Flag-magnetic beads, respectively. Precipitates were subjected to SDSPAGE and examined by immunoblot with anti PPARβ/δ antibodies. b Transactivation assays in Raw264.7 cells transfected with a PPRE-driven luciferase reporter. After nucleofection with PPRE X3-TK-luc and pRL-TK, Raw264.7 cells were serum starved for 8 h, then exposed to H 2 O 2 (200 μM), GW0742 (1 μM), or both for 24 h, and luciferase activity was determined, n = 3 in each group, P (ctr vs. H2O2) = 0.0003, P (ctr vs.GW0742) < 0.0001, P (GW0742 vs.H2O2+GW0742) = 0.0047. c Transactivation assays in COS-7 cells transfected with a PPRE-driven luciferase reporter. After transfection with PPRE X3-TK-luc, FABP5, and pRL-TK, cells were serum starved for 8 h, then treated with H 2 O 2 (200 μM), GW0742 (1 μM), or both for 24 h, and luciferase activity was measured, n = 3 in each group, *** P < 0.0001. d ChIP analysis of FABP5 recruitment to the PPREs of PPARβ/δ target gene promoters in Raw 264.7 cells after exposure to H 2 O 2 (200 μM) for 1 h. ChIP signals were quantified by qPCR, n = 3 in each group, P (ADRP, ctr vs. H2O2) = 0.001, P (FIAF, ctr vs. H2O2) < 0.0001. e mRNA levels of Adrp , Fiaf , and Cpt1a in RAW264.7 cells after treatment with BMS309403 (50 μM) for 2 h, stimulation with GW0742 (1 μM) for 30 min, and exposure to H 2 O 2 (200 μM) for 4 h, as determined by qPCR, n = 3 in each group, P ( Adrp , ctr vs. GW0742) < 0.0001, P ( Adrp , GW0742 vs. GW0742+BMS309403) = 0.0009, P ( Fiaf , ctr vs. GW0742) = 0.001, P ( Fiaf , GW0742 vs. GW0742+BMS309403) = 0.001, P ( Cpt1α , ctr vs. GW0742) < 0.0001, P ( Cpt1α , GW0742 vs. GW0742+BMS309403) < 0.0001. f Co-IP for S-glutathionylation of FABP5 in COS-7 cells overexpressing pXJ40-3xFlag-FABP5 WT or G114R and exposed to H 2 O 2 (200 μM) for 15 min (IP, GSH; IB, FABP5). Whole-cell lysates confirm the expression of FABP5 and β-actin (DTT, negative control). All samples were biologically independent and three or more independent experiments were performed. All quantitative data are shown as mean ± SEM and analyzed with a 95% confidence interval. One-way ANOVA followed by Tukey’s post-hoc test for ( b – e ). * P < 0.05, ** P < 0.01, *** P < 0.001. Source data are provided as a Source Data file.
Techniques Used: In Vitro, Recombinant, Purification, Incubation, Magnetic Beads, Western Blot, Transfection, Luciferase, Activity Assay, Co-Immunoprecipitation Assay, Expressing, Negative Control
fabp5 (Proteintech)
Structured Review
Fabp5, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fabp5/product/Proteintech
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages"
Article Title: Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages
Journal: Nature Communications
doi: 10.1038/s41467-021-27428-9
Figure Legend Snippet: a Schematic of the enrichment and quantitative analysis for SSG-modified Cys-peptides. b Enrichment of protein SSG and LC–MS/MS in BMDMs exposed to H 2 O 2 (200 μM) for 0, 15 min. Gene ontology annotations for biological process of proteins with significant S-glutathionylation alterations found to be increased or decreased in any stage by >1.2-fold compared to control. The slice for metabolic process is slightly displaced from the rest of the pie chart. c Alterations in S-glutathionylation sites under exposure to H 2 O 2 [shown as fold changes of protein S-glutathionylation (H 2 O 2 treated/control). Gray, identified protein sites; blue, metabolism-related differential proteins; orange, FABP5]. d mRNA levels of Ptbp1 , Otub1 , Ctsz , Gapdh , and Fabp5 in BMDMs as evaluated by qPCR, n = 3 biologically independent samples over 3 independent experiments, data are shown as mean ± SEM and analyzed with a 95% confidence interval, P < 0.0001, one-way ANOVA is followed by Tukey’s post-hoc test. Source data are provided as a Source Data file.
Techniques Used: Modification, Liquid Chromatography with Mass Spectroscopy
Figure Legend Snippet: a mRNA levels of FABP family members in RAW264.7 cells as determined by qPCR, n = 3 biologically independent samples over three independent experiments, data are presented as mean ± SEM and analyzed with a 95% confidence interval, P <0.0001, N.D, not detected, one-way ANOVA is followed by Tukey’s post-hoc test. b Protein levels of FABP5 in macrophages (MH-S), lung cancer cells (A549), epithelial cells (MLE-12), endothelial cells (HUVEC), fibroblasts (HFL1), and neutrophils (primary neutrophils) as evaluated by immunoblot. c Levels of FABP5 evaluated by immunoblot in RAW264.7 cells exposed to H 2 O 2 (200 μM) for indicated time (β-actin, loading control). d mRNA levels of Fabp5 in RAW264.7 cells after exposure to H 2 O 2 (200 μM) for indicated time as determined by qPCR, n = 3 biologically independent samples over three independent experiments, data are shown as mean ± SEM and analyzed with a 95% confidence interval, one-way ANOVA is followed by Tukey’s post-hoc test. e Co-IP of S-glutathionylation of FABP5 in COS-7 cells co-transfected with pXJ40-3xFlag-FABP5 and pcDNA3.1-3xFlag-Grx1 (or vector) and exposed for 15 min to H 2 O 2 (200 μM) at 24 h post-transfection (IP, GSH; IB, FABP5). Whole cell lysates confirm the expression of FABP5, Grx1, and β-actin (DTT, negative control). f Co-IP showing S-glutathionylation of FABP5 in BMDMs (from control or Grx1 KO mice) after exposure to H 2 O 2 (200 μM) for 15 min (IP, GSH; IB, FABP5). Whole cell lysates confirm the expression of FABP5, Grx1, and β-actin (DTT, negative control). g Immunoblotting analysis of reducing or non-reducing SDS–PAGE of RAW264.7 cells after exposure to H 2 O 2 (at the indicated concentration) for 15 min. h COS-7 cell lysates subjected to SDS-PAGE under reducing or non-reducing conditions after transfection of pXJ40-3xFlag vector or pXJ40-3xFlag-FABP5 and exposure to H 2 O 2 (200 μM) for 15 min. i Co-IP for S-glutathionylation of FABP5 in WT BMDMs after treatment with LPS (100 ng/mL) for 15 min (IP, GSH; IB, FABP5). Whole cell lysates confirm the expression of FABP5 and β-actin. j S-glutathionylation of FABP5 in lung tissues from Grx1 fl/fl and Grx1 fl/fl LysM cre mouse 24 h following intratracheal administration of PBS or LPS. Source data are provided as a Source Data file.
Techniques Used: Western Blot, Co-Immunoprecipitation Assay, Transfection, Plasmid Preparation, Expressing, Negative Control, SDS Page, Concentration Assay
Figure Legend Snippet: a – c Immunoblot analysis of FABP5 binding to ULCFA ( a ), SLCFA ( b ) or ULCFA with Grx1 treatment ( c ). Purified recombinant FABP5 protein was incubated with GSH plus H 2 O 2 or GSSG for 15 min, then mixed with Biotin-ULCFA or Biotin-SLCFA in the absence or presence of BMS309403 or linoleic acid or Grx1. FABP5 interacted with the Biotin-ULCFA or Biotin-SLCFA was captured using streptavidin magnetic beads. d Immunofluorescence staining of BMDMs after exposure to H 2 O 2 (200 μM) for 30 min (green, FABP5; blue, DAPI; scale bars, 10 μm). e Quantitative analysis of the ratio of nuclear/cytoplasmic fluorescence intensity in BMDMs as in ( d ), n = 10 in each group, P (ctr vs. ctr H2O2) = 0.0172, P (ctr H2O2 vs. Grx1 KO H2O2) <0.0001. f Immunoblot analysis of cytoplasmic and nuclear FABP5 in COS-7 cells. COS-7 cells were transfected with pXJ40-3xFlag vector or pXJ40-3xFlag-FABP5 followed by exposure to H 2 O 2 (200 μM) for 1 h. Lamin B1 (nuclear fraction) and GAPDH (cytoplasmic fraction) are loading controls. g Immunoblots with antibodies against the indicated proteins in nuclear and cytoplasmic fractions from COS-7 cells co-transfected with pXJ40-3xFlag-FABP5 (or vector) and pcDNA3.1-3xFlag-Grx1 (or vector) for 24 h, then exposed to H 2 O 2 (200 μM) for 1 h. h Immunoblots against the indicated proteins of cytoplasmic and nuclear extracts from BMDMs exposed to H 2 O 2 (200 μM) for 1 h. i mRNA expression of Il1b , Il6 , and Tnfα in BMDMs from mice stimulated with LPS (100 ng/mL) for 4 h, as evaluated by qPCR, n = 3 in each group, P ( Il1b , Ctr vs. Ctr+LPS) = 0.0013, P ( Il1b , Ctr+LPS vs. Grx1 KO+LPS) = 0.0091, *** P < 0.0001. j mRNA levels of Il1b , Il6 , and Tnfα in BMDMs pre-treated with an FABP5 inhibitor (SBFI26, 100 μM) for 2 h and stimulated with LPS (100 ng/mL) for 4 h, as determined by qPCR, n = 3 in each group, *** P < 0.0001. k mRNA levels of Il1b , Il6 , and Tnfα in BMDMs after treated with SBFI26 (100 μM) for 2 h and stimulation with LPS (100 ng/mL) for 4 h, as evaluated by qPCR, n = 3 in each group, P ( Il1b , Ctr+LPS vs. Ctr+LPS+inhibitor) < 0.0001, P ( Il16 , Ctr+LPS vs. Ctr+LPS+inhibitor) < 0.0001, P ( Tnfα , Ctr+LPS vs. Ctr+LPS+inhibitor) = 0.0046. All samples were biologically independent and three or more independent experiments were performed. All quantitative data are shown as mean ± SEM and analyzed with a 95% confidence interval. One-way ANOVA followed by Tukey’s post-hoc test for (e, i-k). * P < 0.05, ** P < 0.01, *** P < 0.001, ns = no significance. Source data are provided as a Source Data file.
Techniques Used: Western Blot, Binding Assay, Purification, Recombinant, Incubation, Magnetic Beads, Immunofluorescence, Staining, Fluorescence, Transfection, Plasmid Preparation, Expressing
Figure Legend Snippet: a Model structure of FABP5 and its 6 cysteines, generated by Pymol and based on the crystal structure of Homo sapiens FABP5 (PDB ID,4LKT). b Mass spectra of a peptide from FABP5 including glutathionylated cysteine 120 and cysteine127. c Immunofluorescence staining (with FABP5) and confocal microscopy imaging of COS-7 cells with overexpression of FABP5 WT, C67S, C87S, C120S, and C127S after exposure to H 2 O 2 (200 μM) for 1 h (green, FABP5; blue, DAPI; scale bars, 10 μm). d Immunoblot analysis of cytoplasmic and nuclear FABP5 in COS-7 cells transfected with FABP5 WT or C127S after exposure to H 2 O 2 (200 μM) for 1 h. Lamin B1 (nuclear fraction) and GAPDH (cytoplasmic fraction) are loading controls. e Model structure of FABP5 interaction with an FA (Fatty Acid, Linoleic Acid), generated by Pymol and based on the crystal structure of FABP5 (PDB ID, 4LKT). f Docking structure of FABP5 in complex with S-glutathionylated Cys127 interacting with an FA (Fatty Acid, Linoleic Acid). g Docking structure of dimer FABP5 (PDB ID, 4AZM, Homo sapiens ) in complex with reduced glutathione (GSH) on Cys127. h Co-IP for S-glutathionylation of FABP5 in COS-7 cells overexpressing pXJ40-3xFlag-FABP5 WT or C127S and exposed to H 2 O 2 (200 μM) for 15 min (IP, GSH; IB, FABP5). Whole-cell lysates confirm the expression of FABP5 and β-actin (DTT, negative control). i Immunoblot analysis of FABP5 fatty acid binding. Purified recombinant FABP5 WT or C127S protein (1 μg) was incubated with GSSG (1 mM) for 15 min, then mixed with Biotin-linoleic acid in the absence or presence of BMS309403 (5 mM) for 30 min. FABP5 that associated with the Biotin-linoleic acid was captured using streptavidin magnetic beads. Source data are provided as a Source Data file.
Techniques Used: Generated, Immunofluorescence, Staining, Confocal Microscopy, Imaging, Over Expression, Western Blot, Transfection, Co-Immunoprecipitation Assay, Expressing, Negative Control, Binding Assay, Purification, Recombinant, Incubation, Magnetic Beads
Figure Legend Snippet: a Volcano plot of RNA-seq transcriptome data displaying the pattern of gene expression values for FABP5 KO BMDMs with overexpression of FABP5 C127S relative to FABP5 WT after exposure to LPS (500 ng/mL) for 24 h [red and blue dots, significantly up-and down-regulated genes ( P < 0.01, |log 2 FC|>1); black dashed lines, boundary for identification of up- or down-regulated genes]. b Heatmap of regulation of the inflammatory response and cytokine transcript production in LPS-stimulated (24 h) BMDMs nucleofected with either pXJ40-3xFlag-FABP5 WT or C127S. Data shown are relative to the calculated Z scores across the samples. Red, relatively high levels of expression; blue, relatively low levels of expression. Each column represents one individual (for a total of 3 per group) and each row represents the expression of a single gene. c Diagram of GO analysis classifying DEGs into biological process groups using Panther ( http://www.pantherdb.org ). Some GO categories with FDR <0.05 are included. GO, gene ontology; DEGs, differentially-expressed genes. d mRNA expression of Il1b , Il6 , and Tnfα in FABP5 KO BMDMs after nucleofection with pXJ40-3xFlag-FABP5 WT or C127S and stimulation with LPS (1 μg/mL) for 24 h, as identified by qPCR, n = 3 in each group, P ( Il6 , FABP5 WT+LPS vs. FABP5 C127S+LPS) = 0.0045, *** P < 0.0001. e mRNA expression of Il1b , Il6 , and Tnfα in Grx1 KO BMDMs after nucleofection of pXJ40-3xFlag-FABP5 WT or C127S and treatment with LPS (500 ng/mL) for 24 h, as determined by qPCR, n = 3 in each group, P ( Il6 , Ctr+FABP5 C127S vs. Grx1 KO+FABP5 C127S) = 0.0004, P ( TNFα , Ctr+FABP5 WT vs. Grx1 KO+FABP5 WT) = 0.0123, *** P < 0.0001(except group Il6 , Ctr+FABP5 C127S vs. Grx1 KO+FABP5 C127S). f H&E staining showing lung histopathological changes in FABP5 fl/fl and FABP5 fl/fl LysM cre mice 24 h after intratracheal administration of PBS or LPS (5 mg/kg). Scale bars, 50 μm. g Total numbers of leukocytes in BALF from FABP5 fl/fl and FABP5 fl/fl LysM cre mice 24 h after intratracheal administration of PBS or LPS (5 mg/kg), n = 4, 4, 9, 8, respectively, *** P < 0.0001. All samples were biologically independent and three or more independent experiments were performed. All quantitative data are shown as mean ± SEM and analyzed with a 95% confidence interval. One-way ANOVA followed by Tukey’s post-hoc test for ( d – e , g ). * P < 0.05, ** P < 0.01, *** P < 0.001. Source data are provided as a Source Data file.
Techniques Used: RNA Sequencing Assay, Expressing, Over Expression, Staining
Figure Legend Snippet: a In vitro pull-down assays. The mouse recombinant FABP5 (WT or C127S) protein with 3xFlag tag purified from E. coli treated with GSSG (1 mM) for 15 min was incubated with COS-7 lysates and precipitated with Flag-magnetic beads, respectively. Precipitates were subjected to SDSPAGE and examined by immunoblot with anti PPARβ/δ antibodies. b Transactivation assays in Raw264.7 cells transfected with a PPRE-driven luciferase reporter. After nucleofection with PPRE X3-TK-luc and pRL-TK, Raw264.7 cells were serum starved for 8 h, then exposed to H 2 O 2 (200 μM), GW0742 (1 μM), or both for 24 h, and luciferase activity was determined, n = 3 in each group, P (ctr vs. H2O2) = 0.0003, P (ctr vs.GW0742) < 0.0001, P (GW0742 vs.H2O2+GW0742) = 0.0047. c Transactivation assays in COS-7 cells transfected with a PPRE-driven luciferase reporter. After transfection with PPRE X3-TK-luc, FABP5, and pRL-TK, cells were serum starved for 8 h, then treated with H 2 O 2 (200 μM), GW0742 (1 μM), or both for 24 h, and luciferase activity was measured, n = 3 in each group, *** P < 0.0001. d ChIP analysis of FABP5 recruitment to the PPREs of PPARβ/δ target gene promoters in Raw 264.7 cells after exposure to H 2 O 2 (200 μM) for 1 h. ChIP signals were quantified by qPCR, n = 3 in each group, P (ADRP, ctr vs. H2O2) = 0.001, P (FIAF, ctr vs. H2O2) < 0.0001. e mRNA levels of Adrp , Fiaf , and Cpt1a in RAW264.7 cells after treatment with BMS309403 (50 μM) for 2 h, stimulation with GW0742 (1 μM) for 30 min, and exposure to H 2 O 2 (200 μM) for 4 h, as determined by qPCR, n = 3 in each group, P ( Adrp , ctr vs. GW0742) < 0.0001, P ( Adrp , GW0742 vs. GW0742+BMS309403) = 0.0009, P ( Fiaf , ctr vs. GW0742) = 0.001, P ( Fiaf , GW0742 vs. GW0742+BMS309403) = 0.001, P ( Cpt1α , ctr vs. GW0742) < 0.0001, P ( Cpt1α , GW0742 vs. GW0742+BMS309403) < 0.0001. f Co-IP for S-glutathionylation of FABP5 in COS-7 cells overexpressing pXJ40-3xFlag-FABP5 WT or G114R and exposed to H 2 O 2 (200 μM) for 15 min (IP, GSH; IB, FABP5). Whole-cell lysates confirm the expression of FABP5 and β-actin (DTT, negative control). All samples were biologically independent and three or more independent experiments were performed. All quantitative data are shown as mean ± SEM and analyzed with a 95% confidence interval. One-way ANOVA followed by Tukey’s post-hoc test for ( b – e ). * P < 0.05, ** P < 0.01, *** P < 0.001. Source data are provided as a Source Data file.
Techniques Used: In Vitro, Recombinant, Purification, Incubation, Magnetic Beads, Western Blot, Transfection, Luciferase, Activity Assay, Co-Immunoprecipitation Assay, Expressing, Negative Control
anti fabp5 antibody (Proteintech)
Structured Review
Anti Fabp5 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti fabp5 antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages"
Article Title: Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages
Journal: Nature Communications
doi: 10.1038/s41467-021-27428-9
Figure Legend Snippet: a Schematic of the enrichment and quantitative analysis for SSG-modified Cys-peptides. b Enrichment of protein SSG and LC–MS/MS in BMDMs exposed to H 2 O 2 (200 μM) for 0, 15 min. Gene ontology annotations for biological process of proteins with significant S-glutathionylation alterations found to be increased or decreased in any stage by >1.2-fold compared to control. The slice for metabolic process is slightly displaced from the rest of the pie chart. c Alterations in S-glutathionylation sites under exposure to H 2 O 2 [shown as fold changes of protein S-glutathionylation (H 2 O 2 treated/control). Gray, identified protein sites; blue, metabolism-related differential proteins; orange, FABP5]. d mRNA levels of Ptbp1 , Otub1 , Ctsz , Gapdh , and Fabp5 in BMDMs as evaluated by qPCR, n = 3 biologically independent samples over 3 independent experiments, data are shown as mean ± SEM and analyzed with a 95% confidence interval, P < 0.0001, one-way ANOVA is followed by Tukey’s post-hoc test. Source data are provided as a Source Data file.
Techniques Used: Modification, Liquid Chromatography with Mass Spectroscopy
Figure Legend Snippet: a mRNA levels of FABP family members in RAW264.7 cells as determined by qPCR, n = 3 biologically independent samples over three independent experiments, data are presented as mean ± SEM and analyzed with a 95% confidence interval, P <0.0001, N.D, not detected, one-way ANOVA is followed by Tukey’s post-hoc test. b Protein levels of FABP5 in macrophages (MH-S), lung cancer cells (A549), epithelial cells (MLE-12), endothelial cells (HUVEC), fibroblasts (HFL1), and neutrophils (primary neutrophils) as evaluated by immunoblot. c Levels of FABP5 evaluated by immunoblot in RAW264.7 cells exposed to H 2 O 2 (200 μM) for indicated time (β-actin, loading control). d mRNA levels of Fabp5 in RAW264.7 cells after exposure to H 2 O 2 (200 μM) for indicated time as determined by qPCR, n = 3 biologically independent samples over three independent experiments, data are shown as mean ± SEM and analyzed with a 95% confidence interval, one-way ANOVA is followed by Tukey’s post-hoc test. e Co-IP of S-glutathionylation of FABP5 in COS-7 cells co-transfected with pXJ40-3xFlag-FABP5 and pcDNA3.1-3xFlag-Grx1 (or vector) and exposed for 15 min to H 2 O 2 (200 μM) at 24 h post-transfection (IP, GSH; IB, FABP5). Whole cell lysates confirm the expression of FABP5, Grx1, and β-actin (DTT, negative control). f Co-IP showing S-glutathionylation of FABP5 in BMDMs (from control or Grx1 KO mice) after exposure to H 2 O 2 (200 μM) for 15 min (IP, GSH; IB, FABP5). Whole cell lysates confirm the expression of FABP5, Grx1, and β-actin (DTT, negative control). g Immunoblotting analysis of reducing or non-reducing SDS–PAGE of RAW264.7 cells after exposure to H 2 O 2 (at the indicated concentration) for 15 min. h COS-7 cell lysates subjected to SDS-PAGE under reducing or non-reducing conditions after transfection of pXJ40-3xFlag vector or pXJ40-3xFlag-FABP5 and exposure to H 2 O 2 (200 μM) for 15 min. i Co-IP for S-glutathionylation of FABP5 in WT BMDMs after treatment with LPS (100 ng/mL) for 15 min (IP, GSH; IB, FABP5). Whole cell lysates confirm the expression of FABP5 and β-actin. j S-glutathionylation of FABP5 in lung tissues from Grx1 fl/fl and Grx1 fl/fl LysM cre mouse 24 h following intratracheal administration of PBS or LPS. Source data are provided as a Source Data file.
Techniques Used: Western Blot, Co-Immunoprecipitation Assay, Transfection, Plasmid Preparation, Expressing, Negative Control, SDS Page, Concentration Assay
Figure Legend Snippet: a – c Immunoblot analysis of FABP5 binding to ULCFA ( a ), SLCFA ( b ) or ULCFA with Grx1 treatment ( c ). Purified recombinant FABP5 protein was incubated with GSH plus H 2 O 2 or GSSG for 15 min, then mixed with Biotin-ULCFA or Biotin-SLCFA in the absence or presence of BMS309403 or linoleic acid or Grx1. FABP5 interacted with the Biotin-ULCFA or Biotin-SLCFA was captured using streptavidin magnetic beads. d Immunofluorescence staining of BMDMs after exposure to H 2 O 2 (200 μM) for 30 min (green, FABP5; blue, DAPI; scale bars, 10 μm). e Quantitative analysis of the ratio of nuclear/cytoplasmic fluorescence intensity in BMDMs as in ( d ), n = 10 in each group, P (ctr vs. ctr H2O2) = 0.0172, P (ctr H2O2 vs. Grx1 KO H2O2) <0.0001. f Immunoblot analysis of cytoplasmic and nuclear FABP5 in COS-7 cells. COS-7 cells were transfected with pXJ40-3xFlag vector or pXJ40-3xFlag-FABP5 followed by exposure to H 2 O 2 (200 μM) for 1 h. Lamin B1 (nuclear fraction) and GAPDH (cytoplasmic fraction) are loading controls. g Immunoblots with antibodies against the indicated proteins in nuclear and cytoplasmic fractions from COS-7 cells co-transfected with pXJ40-3xFlag-FABP5 (or vector) and pcDNA3.1-3xFlag-Grx1 (or vector) for 24 h, then exposed to H 2 O 2 (200 μM) for 1 h. h Immunoblots against the indicated proteins of cytoplasmic and nuclear extracts from BMDMs exposed to H 2 O 2 (200 μM) for 1 h. i mRNA expression of Il1b , Il6 , and Tnfα in BMDMs from mice stimulated with LPS (100 ng/mL) for 4 h, as evaluated by qPCR, n = 3 in each group, P ( Il1b , Ctr vs. Ctr+LPS) = 0.0013, P ( Il1b , Ctr+LPS vs. Grx1 KO+LPS) = 0.0091, *** P < 0.0001. j mRNA levels of Il1b , Il6 , and Tnfα in BMDMs pre-treated with an FABP5 inhibitor (SBFI26, 100 μM) for 2 h and stimulated with LPS (100 ng/mL) for 4 h, as determined by qPCR, n = 3 in each group, *** P < 0.0001. k mRNA levels of Il1b , Il6 , and Tnfα in BMDMs after treated with SBFI26 (100 μM) for 2 h and stimulation with LPS (100 ng/mL) for 4 h, as evaluated by qPCR, n = 3 in each group, P ( Il1b , Ctr+LPS vs. Ctr+LPS+inhibitor) < 0.0001, P ( Il16 , Ctr+LPS vs. Ctr+LPS+inhibitor) < 0.0001, P ( Tnfα , Ctr+LPS vs. Ctr+LPS+inhibitor) = 0.0046. All samples were biologically independent and three or more independent experiments were performed. All quantitative data are shown as mean ± SEM and analyzed with a 95% confidence interval. One-way ANOVA followed by Tukey’s post-hoc test for (e, i-k). * P < 0.05, ** P < 0.01, *** P < 0.001, ns = no significance. Source data are provided as a Source Data file.
Techniques Used: Western Blot, Binding Assay, Purification, Recombinant, Incubation, Magnetic Beads, Immunofluorescence, Staining, Fluorescence, Transfection, Plasmid Preparation, Expressing
Figure Legend Snippet: a Model structure of FABP5 and its 6 cysteines, generated by Pymol and based on the crystal structure of Homo sapiens FABP5 (PDB ID,4LKT). b Mass spectra of a peptide from FABP5 including glutathionylated cysteine 120 and cysteine127. c Immunofluorescence staining (with FABP5) and confocal microscopy imaging of COS-7 cells with overexpression of FABP5 WT, C67S, C87S, C120S, and C127S after exposure to H 2 O 2 (200 μM) for 1 h (green, FABP5; blue, DAPI; scale bars, 10 μm). d Immunoblot analysis of cytoplasmic and nuclear FABP5 in COS-7 cells transfected with FABP5 WT or C127S after exposure to H 2 O 2 (200 μM) for 1 h. Lamin B1 (nuclear fraction) and GAPDH (cytoplasmic fraction) are loading controls. e Model structure of FABP5 interaction with an FA (Fatty Acid, Linoleic Acid), generated by Pymol and based on the crystal structure of FABP5 (PDB ID, 4LKT). f Docking structure of FABP5 in complex with S-glutathionylated Cys127 interacting with an FA (Fatty Acid, Linoleic Acid). g Docking structure of dimer FABP5 (PDB ID, 4AZM, Homo sapiens ) in complex with reduced glutathione (GSH) on Cys127. h Co-IP for S-glutathionylation of FABP5 in COS-7 cells overexpressing pXJ40-3xFlag-FABP5 WT or C127S and exposed to H 2 O 2 (200 μM) for 15 min (IP, GSH; IB, FABP5). Whole-cell lysates confirm the expression of FABP5 and β-actin (DTT, negative control). i Immunoblot analysis of FABP5 fatty acid binding. Purified recombinant FABP5 WT or C127S protein (1 μg) was incubated with GSSG (1 mM) for 15 min, then mixed with Biotin-linoleic acid in the absence or presence of BMS309403 (5 mM) for 30 min. FABP5 that associated with the Biotin-linoleic acid was captured using streptavidin magnetic beads. Source data are provided as a Source Data file.
Techniques Used: Generated, Immunofluorescence, Staining, Confocal Microscopy, Imaging, Over Expression, Western Blot, Transfection, Co-Immunoprecipitation Assay, Expressing, Negative Control, Binding Assay, Purification, Recombinant, Incubation, Magnetic Beads
Figure Legend Snippet: a Volcano plot of RNA-seq transcriptome data displaying the pattern of gene expression values for FABP5 KO BMDMs with overexpression of FABP5 C127S relative to FABP5 WT after exposure to LPS (500 ng/mL) for 24 h [red and blue dots, significantly up-and down-regulated genes ( P < 0.01, |log 2 FC|>1); black dashed lines, boundary for identification of up- or down-regulated genes]. b Heatmap of regulation of the inflammatory response and cytokine transcript production in LPS-stimulated (24 h) BMDMs nucleofected with either pXJ40-3xFlag-FABP5 WT or C127S. Data shown are relative to the calculated Z scores across the samples. Red, relatively high levels of expression; blue, relatively low levels of expression. Each column represents one individual (for a total of 3 per group) and each row represents the expression of a single gene. c Diagram of GO analysis classifying DEGs into biological process groups using Panther ( http://www.pantherdb.org ). Some GO categories with FDR <0.05 are included. GO, gene ontology; DEGs, differentially-expressed genes. d mRNA expression of Il1b , Il6 , and Tnfα in FABP5 KO BMDMs after nucleofection with pXJ40-3xFlag-FABP5 WT or C127S and stimulation with LPS (1 μg/mL) for 24 h, as identified by qPCR, n = 3 in each group, P ( Il6 , FABP5 WT+LPS vs. FABP5 C127S+LPS) = 0.0045, *** P < 0.0001. e mRNA expression of Il1b , Il6 , and Tnfα in Grx1 KO BMDMs after nucleofection of pXJ40-3xFlag-FABP5 WT or C127S and treatment with LPS (500 ng/mL) for 24 h, as determined by qPCR, n = 3 in each group, P ( Il6 , Ctr+FABP5 C127S vs. Grx1 KO+FABP5 C127S) = 0.0004, P ( TNFα , Ctr+FABP5 WT vs. Grx1 KO+FABP5 WT) = 0.0123, *** P < 0.0001(except group Il6 , Ctr+FABP5 C127S vs. Grx1 KO+FABP5 C127S). f H&E staining showing lung histopathological changes in FABP5 fl/fl and FABP5 fl/fl LysM cre mice 24 h after intratracheal administration of PBS or LPS (5 mg/kg). Scale bars, 50 μm. g Total numbers of leukocytes in BALF from FABP5 fl/fl and FABP5 fl/fl LysM cre mice 24 h after intratracheal administration of PBS or LPS (5 mg/kg), n = 4, 4, 9, 8, respectively, *** P < 0.0001. All samples were biologically independent and three or more independent experiments were performed. All quantitative data are shown as mean ± SEM and analyzed with a 95% confidence interval. One-way ANOVA followed by Tukey’s post-hoc test for ( d – e , g ). * P < 0.05, ** P < 0.01, *** P < 0.001. Source data are provided as a Source Data file.
Techniques Used: RNA Sequencing Assay, Expressing, Over Expression, Staining
Figure Legend Snippet: a In vitro pull-down assays. The mouse recombinant FABP5 (WT or C127S) protein with 3xFlag tag purified from E. coli treated with GSSG (1 mM) for 15 min was incubated with COS-7 lysates and precipitated with Flag-magnetic beads, respectively. Precipitates were subjected to SDSPAGE and examined by immunoblot with anti PPARβ/δ antibodies. b Transactivation assays in Raw264.7 cells transfected with a PPRE-driven luciferase reporter. After nucleofection with PPRE X3-TK-luc and pRL-TK, Raw264.7 cells were serum starved for 8 h, then exposed to H 2 O 2 (200 μM), GW0742 (1 μM), or both for 24 h, and luciferase activity was determined, n = 3 in each group, P (ctr vs. H2O2) = 0.0003, P (ctr vs.GW0742) < 0.0001, P (GW0742 vs.H2O2+GW0742) = 0.0047. c Transactivation assays in COS-7 cells transfected with a PPRE-driven luciferase reporter. After transfection with PPRE X3-TK-luc, FABP5, and pRL-TK, cells were serum starved for 8 h, then treated with H 2 O 2 (200 μM), GW0742 (1 μM), or both for 24 h, and luciferase activity was measured, n = 3 in each group, *** P < 0.0001. d ChIP analysis of FABP5 recruitment to the PPREs of PPARβ/δ target gene promoters in Raw 264.7 cells after exposure to H 2 O 2 (200 μM) for 1 h. ChIP signals were quantified by qPCR, n = 3 in each group, P (ADRP, ctr vs. H2O2) = 0.001, P (FIAF, ctr vs. H2O2) < 0.0001. e mRNA levels of Adrp , Fiaf , and Cpt1a in RAW264.7 cells after treatment with BMS309403 (50 μM) for 2 h, stimulation with GW0742 (1 μM) for 30 min, and exposure to H 2 O 2 (200 μM) for 4 h, as determined by qPCR, n = 3 in each group, P ( Adrp , ctr vs. GW0742) < 0.0001, P ( Adrp , GW0742 vs. GW0742+BMS309403) = 0.0009, P ( Fiaf , ctr vs. GW0742) = 0.001, P ( Fiaf , GW0742 vs. GW0742+BMS309403) = 0.001, P ( Cpt1α , ctr vs. GW0742) < 0.0001, P ( Cpt1α , GW0742 vs. GW0742+BMS309403) < 0.0001. f Co-IP for S-glutathionylation of FABP5 in COS-7 cells overexpressing pXJ40-3xFlag-FABP5 WT or G114R and exposed to H 2 O 2 (200 μM) for 15 min (IP, GSH; IB, FABP5). Whole-cell lysates confirm the expression of FABP5 and β-actin (DTT, negative control). All samples were biologically independent and three or more independent experiments were performed. All quantitative data are shown as mean ± SEM and analyzed with a 95% confidence interval. One-way ANOVA followed by Tukey’s post-hoc test for ( b – e ). * P < 0.05, ** P < 0.01, *** P < 0.001. Source data are provided as a Source Data file.
Techniques Used: In Vitro, Recombinant, Purification, Incubation, Magnetic Beads, Western Blot, Transfection, Luciferase, Activity Assay, Co-Immunoprecipitation Assay, Expressing, Negative Control
anti fabp5 (Proteintech)
Structured Review
Anti Fabp5, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti fabp5/product/Proteintech
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages"
Article Title: Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages
Journal: Nature Communications
doi: 10.1038/s41467-021-27428-9
Figure Legend Snippet: a Schematic of the enrichment and quantitative analysis for SSG-modified Cys-peptides. b Enrichment of protein SSG and LC–MS/MS in BMDMs exposed to H 2 O 2 (200 μM) for 0, 15 min. Gene ontology annotations for biological process of proteins with significant S-glutathionylation alterations found to be increased or decreased in any stage by >1.2-fold compared to control. The slice for metabolic process is slightly displaced from the rest of the pie chart. c Alterations in S-glutathionylation sites under exposure to H 2 O 2 [shown as fold changes of protein S-glutathionylation (H 2 O 2 treated/control). Gray, identified protein sites; blue, metabolism-related differential proteins; orange, FABP5]. d mRNA levels of Ptbp1 , Otub1 , Ctsz , Gapdh , and Fabp5 in BMDMs as evaluated by qPCR, n = 3 biologically independent samples over 3 independent experiments, data are shown as mean ± SEM and analyzed with a 95% confidence interval, P < 0.0001, one-way ANOVA is followed by Tukey’s post-hoc test. Source data are provided as a Source Data file.
Techniques Used: Modification, Liquid Chromatography with Mass Spectroscopy
Figure Legend Snippet: a mRNA levels of FABP family members in RAW264.7 cells as determined by qPCR, n = 3 biologically independent samples over three independent experiments, data are presented as mean ± SEM and analyzed with a 95% confidence interval, P <0.0001, N.D, not detected, one-way ANOVA is followed by Tukey’s post-hoc test. b Protein levels of FABP5 in macrophages (MH-S), lung cancer cells (A549), epithelial cells (MLE-12), endothelial cells (HUVEC), fibroblasts (HFL1), and neutrophils (primary neutrophils) as evaluated by immunoblot. c Levels of FABP5 evaluated by immunoblot in RAW264.7 cells exposed to H 2 O 2 (200 μM) for indicated time (β-actin, loading control). d mRNA levels of Fabp5 in RAW264.7 cells after exposure to H 2 O 2 (200 μM) for indicated time as determined by qPCR, n = 3 biologically independent samples over three independent experiments, data are shown as mean ± SEM and analyzed with a 95% confidence interval, one-way ANOVA is followed by Tukey’s post-hoc test. e Co-IP of S-glutathionylation of FABP5 in COS-7 cells co-transfected with pXJ40-3xFlag-FABP5 and pcDNA3.1-3xFlag-Grx1 (or vector) and exposed for 15 min to H 2 O 2 (200 μM) at 24 h post-transfection (IP, GSH; IB, FABP5). Whole cell lysates confirm the expression of FABP5, Grx1, and β-actin (DTT, negative control). f Co-IP showing S-glutathionylation of FABP5 in BMDMs (from control or Grx1 KO mice) after exposure to H 2 O 2 (200 μM) for 15 min (IP, GSH; IB, FABP5). Whole cell lysates confirm the expression of FABP5, Grx1, and β-actin (DTT, negative control). g Immunoblotting analysis of reducing or non-reducing SDS–PAGE of RAW264.7 cells after exposure to H 2 O 2 (at the indicated concentration) for 15 min. h COS-7 cell lysates subjected to SDS-PAGE under reducing or non-reducing conditions after transfection of pXJ40-3xFlag vector or pXJ40-3xFlag-FABP5 and exposure to H 2 O 2 (200 μM) for 15 min. i Co-IP for S-glutathionylation of FABP5 in WT BMDMs after treatment with LPS (100 ng/mL) for 15 min (IP, GSH; IB, FABP5). Whole cell lysates confirm the expression of FABP5 and β-actin. j S-glutathionylation of FABP5 in lung tissues from Grx1 fl/fl and Grx1 fl/fl LysM cre mouse 24 h following intratracheal administration of PBS or LPS. Source data are provided as a Source Data file.
Techniques Used: Western Blot, Co-Immunoprecipitation Assay, Transfection, Plasmid Preparation, Expressing, Negative Control, SDS Page, Concentration Assay
Figure Legend Snippet: a – c Immunoblot analysis of FABP5 binding to ULCFA ( a ), SLCFA ( b ) or ULCFA with Grx1 treatment ( c ). Purified recombinant FABP5 protein was incubated with GSH plus H 2 O 2 or GSSG for 15 min, then mixed with Biotin-ULCFA or Biotin-SLCFA in the absence or presence of BMS309403 or linoleic acid or Grx1. FABP5 interacted with the Biotin-ULCFA or Biotin-SLCFA was captured using streptavidin magnetic beads. d Immunofluorescence staining of BMDMs after exposure to H 2 O 2 (200 μM) for 30 min (green, FABP5; blue, DAPI; scale bars, 10 μm). e Quantitative analysis of the ratio of nuclear/cytoplasmic fluorescence intensity in BMDMs as in ( d ), n = 10 in each group, P (ctr vs. ctr H2O2) = 0.0172, P (ctr H2O2 vs. Grx1 KO H2O2) <0.0001. f Immunoblot analysis of cytoplasmic and nuclear FABP5 in COS-7 cells. COS-7 cells were transfected with pXJ40-3xFlag vector or pXJ40-3xFlag-FABP5 followed by exposure to H 2 O 2 (200 μM) for 1 h. Lamin B1 (nuclear fraction) and GAPDH (cytoplasmic fraction) are loading controls. g Immunoblots with antibodies against the indicated proteins in nuclear and cytoplasmic fractions from COS-7 cells co-transfected with pXJ40-3xFlag-FABP5 (or vector) and pcDNA3.1-3xFlag-Grx1 (or vector) for 24 h, then exposed to H 2 O 2 (200 μM) for 1 h. h Immunoblots against the indicated proteins of cytoplasmic and nuclear extracts from BMDMs exposed to H 2 O 2 (200 μM) for 1 h. i mRNA expression of Il1b , Il6 , and Tnfα in BMDMs from mice stimulated with LPS (100 ng/mL) for 4 h, as evaluated by qPCR, n = 3 in each group, P ( Il1b , Ctr vs. Ctr+LPS) = 0.0013, P ( Il1b , Ctr+LPS vs. Grx1 KO+LPS) = 0.0091, *** P < 0.0001. j mRNA levels of Il1b , Il6 , and Tnfα in BMDMs pre-treated with an FABP5 inhibitor (SBFI26, 100 μM) for 2 h and stimulated with LPS (100 ng/mL) for 4 h, as determined by qPCR, n = 3 in each group, *** P < 0.0001. k mRNA levels of Il1b , Il6 , and Tnfα in BMDMs after treated with SBFI26 (100 μM) for 2 h and stimulation with LPS (100 ng/mL) for 4 h, as evaluated by qPCR, n = 3 in each group, P ( Il1b , Ctr+LPS vs. Ctr+LPS+inhibitor) < 0.0001, P ( Il16 , Ctr+LPS vs. Ctr+LPS+inhibitor) < 0.0001, P ( Tnfα , Ctr+LPS vs. Ctr+LPS+inhibitor) = 0.0046. All samples were biologically independent and three or more independent experiments were performed. All quantitative data are shown as mean ± SEM and analyzed with a 95% confidence interval. One-way ANOVA followed by Tukey’s post-hoc test for (e, i-k). * P < 0.05, ** P < 0.01, *** P < 0.001, ns = no significance. Source data are provided as a Source Data file.
Techniques Used: Western Blot, Binding Assay, Purification, Recombinant, Incubation, Magnetic Beads, Immunofluorescence, Staining, Fluorescence, Transfection, Plasmid Preparation, Expressing
Figure Legend Snippet: a Model structure of FABP5 and its 6 cysteines, generated by Pymol and based on the crystal structure of Homo sapiens FABP5 (PDB ID,4LKT). b Mass spectra of a peptide from FABP5 including glutathionylated cysteine 120 and cysteine127. c Immunofluorescence staining (with FABP5) and confocal microscopy imaging of COS-7 cells with overexpression of FABP5 WT, C67S, C87S, C120S, and C127S after exposure to H 2 O 2 (200 μM) for 1 h (green, FABP5; blue, DAPI; scale bars, 10 μm). d Immunoblot analysis of cytoplasmic and nuclear FABP5 in COS-7 cells transfected with FABP5 WT or C127S after exposure to H 2 O 2 (200 μM) for 1 h. Lamin B1 (nuclear fraction) and GAPDH (cytoplasmic fraction) are loading controls. e Model structure of FABP5 interaction with an FA (Fatty Acid, Linoleic Acid), generated by Pymol and based on the crystal structure of FABP5 (PDB ID, 4LKT). f Docking structure of FABP5 in complex with S-glutathionylated Cys127 interacting with an FA (Fatty Acid, Linoleic Acid). g Docking structure of dimer FABP5 (PDB ID, 4AZM, Homo sapiens ) in complex with reduced glutathione (GSH) on Cys127. h Co-IP for S-glutathionylation of FABP5 in COS-7 cells overexpressing pXJ40-3xFlag-FABP5 WT or C127S and exposed to H 2 O 2 (200 μM) for 15 min (IP, GSH; IB, FABP5). Whole-cell lysates confirm the expression of FABP5 and β-actin (DTT, negative control). i Immunoblot analysis of FABP5 fatty acid binding. Purified recombinant FABP5 WT or C127S protein (1 μg) was incubated with GSSG (1 mM) for 15 min, then mixed with Biotin-linoleic acid in the absence or presence of BMS309403 (5 mM) for 30 min. FABP5 that associated with the Biotin-linoleic acid was captured using streptavidin magnetic beads. Source data are provided as a Source Data file.
Techniques Used: Generated, Immunofluorescence, Staining, Confocal Microscopy, Imaging, Over Expression, Western Blot, Transfection, Co-Immunoprecipitation Assay, Expressing, Negative Control, Binding Assay, Purification, Recombinant, Incubation, Magnetic Beads
Figure Legend Snippet: a Volcano plot of RNA-seq transcriptome data displaying the pattern of gene expression values for FABP5 KO BMDMs with overexpression of FABP5 C127S relative to FABP5 WT after exposure to LPS (500 ng/mL) for 24 h [red and blue dots, significantly up-and down-regulated genes ( P < 0.01, |log 2 FC|>1); black dashed lines, boundary for identification of up- or down-regulated genes]. b Heatmap of regulation of the inflammatory response and cytokine transcript production in LPS-stimulated (24 h) BMDMs nucleofected with either pXJ40-3xFlag-FABP5 WT or C127S. Data shown are relative to the calculated Z scores across the samples. Red, relatively high levels of expression; blue, relatively low levels of expression. Each column represents one individual (for a total of 3 per group) and each row represents the expression of a single gene. c Diagram of GO analysis classifying DEGs into biological process groups using Panther ( http://www.pantherdb.org ). Some GO categories with FDR <0.05 are included. GO, gene ontology; DEGs, differentially-expressed genes. d mRNA expression of Il1b , Il6 , and Tnfα in FABP5 KO BMDMs after nucleofection with pXJ40-3xFlag-FABP5 WT or C127S and stimulation with LPS (1 μg/mL) for 24 h, as identified by qPCR, n = 3 in each group, P ( Il6 , FABP5 WT+LPS vs. FABP5 C127S+LPS) = 0.0045, *** P < 0.0001. e mRNA expression of Il1b , Il6 , and Tnfα in Grx1 KO BMDMs after nucleofection of pXJ40-3xFlag-FABP5 WT or C127S and treatment with LPS (500 ng/mL) for 24 h, as determined by qPCR, n = 3 in each group, P ( Il6 , Ctr+FABP5 C127S vs. Grx1 KO+FABP5 C127S) = 0.0004, P ( TNFα , Ctr+FABP5 WT vs. Grx1 KO+FABP5 WT) = 0.0123, *** P < 0.0001(except group Il6 , Ctr+FABP5 C127S vs. Grx1 KO+FABP5 C127S). f H&E staining showing lung histopathological changes in FABP5 fl/fl and FABP5 fl/fl LysM cre mice 24 h after intratracheal administration of PBS or LPS (5 mg/kg). Scale bars, 50 μm. g Total numbers of leukocytes in BALF from FABP5 fl/fl and FABP5 fl/fl LysM cre mice 24 h after intratracheal administration of PBS or LPS (5 mg/kg), n = 4, 4, 9, 8, respectively, *** P < 0.0001. All samples were biologically independent and three or more independent experiments were performed. All quantitative data are shown as mean ± SEM and analyzed with a 95% confidence interval. One-way ANOVA followed by Tukey’s post-hoc test for ( d – e , g ). * P < 0.05, ** P < 0.01, *** P < 0.001. Source data are provided as a Source Data file.
Techniques Used: RNA Sequencing Assay, Expressing, Over Expression, Staining
Figure Legend Snippet: a In vitro pull-down assays. The mouse recombinant FABP5 (WT or C127S) protein with 3xFlag tag purified from E. coli treated with GSSG (1 mM) for 15 min was incubated with COS-7 lysates and precipitated with Flag-magnetic beads, respectively. Precipitates were subjected to SDSPAGE and examined by immunoblot with anti PPARβ/δ antibodies. b Transactivation assays in Raw264.7 cells transfected with a PPRE-driven luciferase reporter. After nucleofection with PPRE X3-TK-luc and pRL-TK, Raw264.7 cells were serum starved for 8 h, then exposed to H 2 O 2 (200 μM), GW0742 (1 μM), or both for 24 h, and luciferase activity was determined, n = 3 in each group, P (ctr vs. H2O2) = 0.0003, P (ctr vs.GW0742) < 0.0001, P (GW0742 vs.H2O2+GW0742) = 0.0047. c Transactivation assays in COS-7 cells transfected with a PPRE-driven luciferase reporter. After transfection with PPRE X3-TK-luc, FABP5, and pRL-TK, cells were serum starved for 8 h, then treated with H 2 O 2 (200 μM), GW0742 (1 μM), or both for 24 h, and luciferase activity was measured, n = 3 in each group, *** P < 0.0001. d ChIP analysis of FABP5 recruitment to the PPREs of PPARβ/δ target gene promoters in Raw 264.7 cells after exposure to H 2 O 2 (200 μM) for 1 h. ChIP signals were quantified by qPCR, n = 3 in each group, P (ADRP, ctr vs. H2O2) = 0.001, P (FIAF, ctr vs. H2O2) < 0.0001. e mRNA levels of Adrp , Fiaf , and Cpt1a in RAW264.7 cells after treatment with BMS309403 (50 μM) for 2 h, stimulation with GW0742 (1 μM) for 30 min, and exposure to H 2 O 2 (200 μM) for 4 h, as determined by qPCR, n = 3 in each group, P ( Adrp , ctr vs. GW0742) < 0.0001, P ( Adrp , GW0742 vs. GW0742+BMS309403) = 0.0009, P ( Fiaf , ctr vs. GW0742) = 0.001, P ( Fiaf , GW0742 vs. GW0742+BMS309403) = 0.001, P ( Cpt1α , ctr vs. GW0742) < 0.0001, P ( Cpt1α , GW0742 vs. GW0742+BMS309403) < 0.0001. f Co-IP for S-glutathionylation of FABP5 in COS-7 cells overexpressing pXJ40-3xFlag-FABP5 WT or G114R and exposed to H 2 O 2 (200 μM) for 15 min (IP, GSH; IB, FABP5). Whole-cell lysates confirm the expression of FABP5 and β-actin (DTT, negative control). All samples were biologically independent and three or more independent experiments were performed. All quantitative data are shown as mean ± SEM and analyzed with a 95% confidence interval. One-way ANOVA followed by Tukey’s post-hoc test for ( b – e ). * P < 0.05, ** P < 0.01, *** P < 0.001. Source data are provided as a Source Data file.
Techniques Used: In Vitro, Recombinant, Purification, Incubation, Magnetic Beads, Western Blot, Transfection, Luciferase, Activity Assay, Co-Immunoprecipitation Assay, Expressing, Negative Control
anti fabp5 (Proteintech)
Structured Review
Anti Fabp5, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti fabp5/product/Proteintech
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Peroxisomal Fatty Acid Oxidation and Glycolysis Are Triggered in Mouse Models of Lesional Atopic Dermatitis"
Article Title: Peroxisomal Fatty Acid Oxidation and Glycolysis Are Triggered in Mouse Models of Lesional Atopic Dermatitis
Journal: JID Innovations
doi: 10.1016/j.xjidi.2021.100033
Figure Legend Snippet: PCR Array Gene List and Respective Fold Changes
Techniques Used: Sequencing, Binding Assay, Transferring
Figure Legend Snippet: Enhanced PPARδ signaling in ft/ft mouse epidermis. Relative mRNA levels of ( a ) Tnfa , ( b ) Il1b, and ( c ) Fabp5 in CTRL and ft/ft mouse epidermis (n = 9–10). ( d ) Representative western blot and immunofluorescence staining showing FABP5 in the epidermis of ft/ft and CTRL mice. ( e ) Nuclear localization of FAPB5 protein in mouse epidermis. The mean fluorescence intensities of FABP5 located in the nuclei are shown and represented by the spectrum of pseudocolors, ascending from black to white (see Materials and Methods). The dashed line indicates the dermal‒epidermal boundary. Bar = 50 μm. Data were analyzed with a Student’s t -test. ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001. CTRL, control; PPAR, peroxisome proliferator–activated receptor.
Techniques Used: Western Blot, Immunofluorescence, Staining, Fluorescence
Figure Legend Snippet: MC903 mouse model of ADL ( a ) Representative H&E staining of ear sections (bar = 200 μm) of MC903-treated mice compared with that of the vehicle-treated CTRLS (n = 7) and ( b ) TEWL values measured on the ears of mice (n = 7). ( c ) qPCR and immunostaining showing mRNA and protein level of ACOX1 in the epidermis of mice treated with MC903 or vehicle. The dashed line indicates the dermal‒epidermal boundary. Bar = 50 μm. mRNA level of ( d ) Acot5 ; ( e ) Crot ; ( f ) PPAR mRNA, Ppar , isoforms; and Fabp5 in the epidermis of mice treated with MC903 or vehicle (n = 7). ( g ) mRNA level and protein abundance of GLUT1 and ( h ) mRNA level of key enzymes of glycolysis as well as of ( i ) Ldha and Pdk1 in the epidermis of mice treated with MC903 or vehicle (n = 7). The dashed line indicates the dermal‒epidermal boundary. Bar = 50 μm. Data were analyzed with a Student’s t -test. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, and ∗∗∗∗ P < 0.0001. ADL, lesional atopic dermatitis; CTRL, control; PPAR, peroxisome proliferator–activated receptor; TEWL, transepidermal water loss.
Techniques Used: Staining, Immunostaining
anti fabp5 (Proteintech)
Structured Review
Anti Fabp5, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti fabp5/product/Proteintech
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Heparin-Binding Protein 17/Fibroblast Growth Factor-Binding Protein-1 Knockout Inhibits Proliferation and Induces Differentiation of Squamous Cell Carcinoma Cells"
Article Title: Heparin-Binding Protein 17/Fibroblast Growth Factor-Binding Protein-1 Knockout Inhibits Proliferation and Induces Differentiation of Squamous Cell Carcinoma Cells
Journal: Cancers
doi: 10.3390/cancers13112684
Figure Legend Snippet: cDNA microarray and proteomic analyses of A431-HBp17-KO2 and A431-WT cells. ( A ) cDNA microarray analysis found 11 cDNAs with greater than 2.5-fold higher expression in A431-HBp17-KO2 cells than in A431-WT cells. ( B ) Seven proteins were found to be expressed at least five times higher in A431-HBp17-KO2 cells than in A431-WT cells. Abbreviations: aldo-keto reductase family 1 member C3 (AKR1C3), keratin1 (KRT1), aldo-keto reductase family 1 member C2 (AKR1C2), carbonic anhydrase 2 (CA2), fatty acid-binding protein 5 (FABP5), secretory leukocyte protease inhibitor (SLPI), serine proteinase inhibitor clade B member 3 (SERPINB3), plasma membrane calcium-transporting ATPase 4 (ATP2B4), S100 calcium-binding protein A8 (S100A8), S100 calcium-binding protein A9 (S100A9), small proline-rich protein 1B (SPRR1B), and small proline-rich protein 1A (SPRR1A).
Techniques Used: Microarray, Expressing, Binding Assay, Protease Inhibitor
Figure Legend Snippet: Top 10 GO terms of upregulated DEGs.
Techniques Used:
Figure Legend Snippet: Knocking out HBp17 induces the expression of cornified envelope-related proteins. ( A ) Upregulation of FABP5, SPRR-A, SPRR-B, IVL, LOR, and FLG mRNAs in A431-HBp17-KO2 cells was evaluated by qRT-PCR. ( B ) In HO-1-N-1-HBp17-KO1, the expression of FABP5, IVL, and FLG mRNAs was elevated. GAPDH levels were used as an internal control. Experiments were performed in triplicate, with the data presented as means ± SD. * p < 0.05. Increased cornified envelope-related protein expression in A431-HBp17-KO2 ( C ) and HO-1-N-1- HBp17-KO1 cells (D) was evaluated by Western blot. ( E ) Immunofluorescence staining for IVL (green) in A431-HBp17-KO2 and HO-1-N-1-HBp17-KO1, A431-WT, and HO-1-N-1-WT cells. Cell nuclei were stained with DAPI (blue). Abbreviations: fatty acid-binding protein 5 (FABP5), small proline-rich protein 1A (SPRR1A), small proline-rich protein 1B (SPRR1B), Involucrin (IVL), Loricrin (LOR), Filaggrin (FLG).
Techniques Used: Expressing, Quantitative RT-PCR, Western Blot, Immunofluorescence, Staining, Binding Assay